Eletrocirurgia: sistemas mono e bipolar em cirurgia videolaparoscópica

O conhecimento das leis físicas e dos mecanismos de funcionamento da eletrocirurgia são de grande importância para o cirurgião. Lesões por eletrocirurgia em laparoscopia têm sido observadas, e estão associadas ao uso do eletrodo monopolar, com freqüência de 1 a 2 lesões a cada 1000 procedimentos.Com relação ao desenvolvimento de lesão, existem vários fatores que influenciam: densidade da corrente; o tipo de onda e de coagulação usadas, com suas respectivas voltagens; as condições de isolamento dos dispositivos; a ocorrência do fenômeno de capacitância; e os riscos oferecidos pelo uso em pacientes com marcapasso. No sistema bipolar, a densidade de corrente encontrada ao redor de seus eletrodos é bem menor, levando a menos lesões e, ainda, elimina vários dos outros mecanismos lesivos, como a placa de retorno e os citados acima. Vários estudos demonstram, em colecistectomias, apendicectomias, polipectomias e outros, que o índice de complicações com o eletrodo bipolar é significativamente menor.<br>the knowledge of the physical laws and of the mechanisms of functioning of electrosurgery are of great importance for the surgeon. Lesions caused by electrosurgery in laparoscopic procedures have been observed, and are associated with the use of monopolar electrode, with the frequency of 1 to 2 lesions in every 1000 procedures. Concerning the development of the lesions, several factors are involved; current density, the waveform and the type of coagulation used, with its respective voltages; the insulation condition of the devices; the occurrence of the phenomenon of capacitance and the risks involved with the use in patients with pacemakers. In bipolar electrosurgery, the current density produced around the electrodes is much lower, causing less tissue damage and, still, eliminating several of the other mechanims of injury, such as the dispersive electrode and those quoted above. Several studies reveal that the incidence of complications with the use of bipolar electrodes in cholecystectomies, appendicectomies, polypectomies and other procedures is significantly lower

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT

Background: Although rare in the general population, highly penetrant germline mutations in CDKN2A are responsible for 5%-40% of melanoma cases reported in melanoma-prone families. We sought to determine whether MELPREDICT was generalizable to a global series of families with melanoma and whether performance improvements can be achieved.Methods: In total, 2116 familial melanoma cases were ascertained by the international GenoMEL Consortium. We recapitulated the MELPREDICT model within our data (GenoMELPREDICT) to assess performance improvements by adding phenotypic risk factors and history of pancreatic cancer. We report areas under the curve (AUC) with 95% confidence intervals (CIs) along with net reclassification indices (NRIs) as performance metrics.Results: MELPREDICT performed well (AUC 0.752, 95% CI 0.730-0.775), and GenoMELPREDICT performance was similar (AUC 0.748, 95% CI 0.726-0.771). Adding a reported history of pancreatic cancer yielded discriminatory improvement (P < .0001) in GenoMELPREDICT (AUC 0.772, 95% CI 0.750-0.793, NRI 0.40). Including phenotypic risk factors did not improve performance.Conclusion: The MELPREDICT model functioned well in a global data set of familial melanoma cases. Adding pancreatic cancer history improved model prediction. GenoMELPREDICT is a simple tool for predicting CDKN2A mutational status among melanoma patients from melanoma-prone families and can aid in directing these patients to receive genetic testing or cancer risk counseling.Hereditary cancer genetic